Diatomic produces DH2 Organ Preservation Solution that prevents ischemia-reperfusion injury. 

Why does this matter?

Every single organ, even healthy organs with successful transplants, are damaged by ischemia-reperfusion injury during transplant. Ischemia-reperfusion injury is the silent crisis behind organ transplantation — the key driver of organ rejection, early graft failure, and the geographic and time constraints that limit how far a donor organ can travel. It's why thousands of organs are discarded every year. 

DH2 changes that equation:

✅ Extends safe cold storage of hearts to 7+ hours
✅ Enables transplantation of marginal organs previously deemed unusable
✅ Improves graft function and accelerates patient recovery
✅ Expands the viable donor pool and the transplant geographic radius

How does DH2 do this?

DH2’s core innovation is a proprietary engineering process that enables stable, controlled dissolution of molecular hydrogen into preservation solution at therapeutically effective concentrations, designed to selectively reduce hydroxyl radical mediated oxidative stress during reperfusion, thereby mitigating ischemia-reperfusion injury.

The mission is simple: better organs, better outcomes, more lives saved.

Diatomic

James Silver

This department provides strategic direction and oversight for the organization.

Diatomic

Org chart

Teams

Executive Leadership

Offices

Diatomic

Org chart

Teams

Executive Leadership

Offices

Related companies